Drug Shortage Report for SODIUM THIOSULFATE INJECTION USP

Last updated on 2020-02-04 History
Report ID 79024
Drug Identification Number 02137186
Brand name SODIUM THIOSULFATE INJECTION USP
Common or Proper name Sodium
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) SODIUM THIOSULFATE
Strength(s) 25%
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10mL Glass vial
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-09
Estimated end date
Actual end date 2020-02-03
Shortage status Resolved
Updated date 2020-02-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-03-20 English Compare
v2 2019-03-20 English Compare
v3 2019-03-20 French Compare
v4 2019-05-02 English Compare
v5 2019-05-02 French Compare
v6 2019-05-09 English Compare
v7 2019-05-09 French Compare
v8 2019-06-30 English Compare
v9 2019-07-03 English Compare
v10 2019-07-03 French Compare
v11 2019-08-10 English Compare
v12 2019-08-28 English Compare
v13 2019-08-28 French Compare
v14 2019-09-07 English Compare
v15 2019-09-09 English Compare
v16 2019-09-09 French Compare
v17 2019-09-10 English Compare
v18 2019-11-20 English Compare
v19 2019-11-20 French Compare
v20 2020-01-29 English Compare

Showing 1 to 20 of 24